Live Trump raises rate on China to 125%, pauses 'reciprocal' tariffs on other countries TSXV - Free Realtime Quote • CAD Grey Wolf Animal Health Corp. (WOLF.V) Follow Compare 0.9600 0.0000 (0.00%) As of April 8 at 12:30:52 PM EDT. Market Open. All News Press Releases SEC Filings Has Grey Wolf Animal Health Corp.'s (CVE:WOLF) Impressive Stock Performance Got Anything to Do With Its Fundamentals? Grey Wolf Animal Health (CVE:WOLF) has had a great run on the share market with its stock up by a significant 30% over... GREY WOLF ANIMAL HEALTH ANNOUNCES THE ACQUISITION OF THE COMPOUNDING PHARMACY OF MANITOBA Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified health company, today announced that it has completed the acquisition (the "Transaction") of 6303021 Manitoba Ltd. (dba.– The Compounding Pharmacy of Manitoba) ("CPM") for total consideration of $22.5 million, including associated real estate, pursuant to a Share Purchase Agreement dated December 2, 2024. GREY WOLF ANIMAL HEALTH REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced financial results for the three- and nine-months ended September 30, 2024. 3 Promising Penny Stocks On TSX With Market Caps Over CA$3M As the Canadian economy experiences a cooling labor market and anticipates further interest rate cuts by the Bank of Canada, financial markets are poised to navigate these shifts with cautious optimism. In this context, penny stocks—often representing smaller or newer companies—remain an intriguing investment area for those seeking growth opportunities at lower price points. When backed by strong financial health, these stocks can offer potential upside without many of the risks typically... GREY WOLF ANIMAL HEALTH ANNOUNCES LAUNCH OF SILEO Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced the Canadian commercial launch of SILEO® (dexmedetomidine hydrochloride oromucosal gel) to veterinary clinics throughout Canada. SILEO builds on Grey Wolf's portfolio dedicated to behaviour and anxiety health in companion animals. Dogs that experience fear and anxiety in response to loud noise such as fireworks now have a new treatment option. SILEO is availabl Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver VANCOUVER, BC / ACCESSWIRE / September 24, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VANCOUVER taking place on September 25-26, 2024, where 50 MicroCap public and private companies will be presenting at the Fairmont Waterfront ... Grey Wolf Animal Health to Present at the 2024 Planet MicroCap Showcase in Vancouver TORONTO, ON / ACCESSWIRE / September 11, 2024 / Grey Wolf Animal Health Corp. (TSXV:WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced that Shawn Aspden, Chair, is scheduled to present a corporate update ... Grey Wolf Animal Health Corp.'s (CVE:WOLF) Stock Is Going Strong: Have Financials A Role To Play? Grey Wolf Animal Health (CVE:WOLF) has had a great run on the share market with its stock up by a significant 28% over... GREY WOLF ANIMAL HEALTH REPORTS RECORD SECOND QUARTER 2024 FINANCIAL RESULTS Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced financial results for the three- and six-months ended June 30, 2024. A Look At The Fair Value Of Grey Wolf Animal Health Corp. (CVE:WOLF) Key Insights The projected fair value for Grey Wolf Animal Health is CA$0.69 based on 2 Stage Free Cash Flow to Equity... GREY WOLF ANIMAL HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced financial results for the three months ended March 31, 2024. Grey Wolf Animal Health Full Year 2023 Earnings: EPS: CA$0.02 (vs CA$0.15 in FY 2022) Grey Wolf Animal Health ( CVE:WOLF ) Full Year 2023 Results Key Financial Results Revenue: CA$25.4m (up 12% from FY... GREY WOLF ANIMAL HEALTH REPORTS FOURTH QUARTER AND YEAR END 2023 FINANCIAL RESULTS Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced financial results for the fourth quarter and year ended December 31, 2023. Performance Overview Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) Return WOLF.V S&P/TSX Composite index (^GSPTSE) YTD -12.73% -3.74% 1-Year +12.94% +5.98% 3-Year -31.43% +8.34%